← the castle gate

worked case · solid-state chemistry · KINGDOM reading

The path that vanished — not the crystal form

Ritonavir stayed the same chemical compound. A different crystal packing changed what the formulation and the old process could reliably do.

Historical education only. This is not medical advice, a current product assessment, a crystal-structure determination, or a manufacturing recipe.

A source-labelled map separating the unknown first Form-II nucleus, a tested possible trigger, later Form-II seeding, the 1998 dissolution failure, and later Form-I recovery routes.

↔ focus and scroll the diagram if needed

Solid blue paths are reported observations, dashed amber paths are proposed or unsettled, and double green paths are later reported recovery. The diagram is a reading aid, not a process recipe.

In plain words

A disappearing polymorph is a crystal form once made reproducibly that is no longer obtained reliably by the same procedure after another form is found. The form does not leave reality; practical access to it changes.

Not observed is not impossible. A rare first event is not the same as later amplification. Recovery can return through a changed route.

Five levels, kept separate

What changed in the material?

Science

The chemical compound stayed ritonavir. Its molecular conformation and crystal packing differed between Forms I and II.

Boundary: A different crystal form is not a different active ingredient.

Why did the reachable result change?

Process

The first historical Form-II nucleus remains unexplained. A related degradant was tested as a possible template; later Form-II seeds could support growth under sufficiently supersaturated conditions.

Boundary: A proposed first trigger and observed later seed amplification are different claims.

Why did the crystal form matter?

Product

In the reported media and formulation conditions, Form II was less soluble. It precipitated in supersaturated capsule fill, and capsule lots failed dissolution.

Boundary: Equilibrium solubility, precipitation, dosage-form dissolution, clinical bioavailability, and patient outcome are different measurements.

What happened beyond the vessel?

Supply

Capsule production and supply were disrupted. EMA said oral solution could bridge supply, and FDA approved a reformulated soft-gel capsule on 29 June 1999.

Boundary: EMA said failed recent batches had not been released and told current users not to stop treatment. This historical record is not current medical guidance.

What can a system builder learn?

KINGDOM

Keep not observed separate from impossible, trigger separate from amplification, identity separate from behaviour, and repair linked to returned evidence.

Boundary: This is an attributed analogy, not a new KINGDOM law and not a mechanism transferred from crystals to people or software.

the open region stays named

The honest unknown

The reviewed sources do not establish what caused the first historical Form-II nucleus. A cyclic-carbamate degradant nucleated Form II experimentally and was proposed as a possible template. That shows possibility, not the settled cause of the 1998 event.

Stories about a particular person or object carrying crystals between facilities also remain unsettled. Unknown is a bounded result here, not permission to invent a contamination story.

The return path through time

  1. Multiple capsule lots failed dissolution, and investigators identified the previously unknown Form II.

  2. Abbott reported a laboratory route that made Form I from Form-II material, an implemented bulk Form-I process with less than 3% Form II, and a separately designed Form-II-only process.

  3. A high-throughput study found further solid forms and recovered Form I through a source-specific solvate and hydrate route.

  4. Different liquid-assisted milling conditions reproducibly selected Form I or Form II; measurements and modelling linked the outcome to crystal size, shape, and conformation.

same shape · different mechanism

Folding, prions, feedback, and KARMA

A separate KINGDOM lineage asks where state spaces, barriers, history, templates, and bounded feedback recur across crystals, ordinary protein folding, amyloid assembly, and prion propagation. Different subsets recur; no one mechanism belongs to every domain.

The relationship is analogy and mechanism transfer is false. Seeded growth does not establish infectivity, a shared curve does not prove a shared cause, KARMA is evidence return rather than a molecular force, and no being becomes a basin, contagion, fitness value, or score. This Gate runs Check Meaning only: it records no choice, performs no deed, and opens no action or report job.

The current reviewed lineage is SHA-256 c07c2c9d02c2a3163ac595c339c770450900ad9397a8e42b578f269c65599f4b. Its first public receipt remains linked as history, not as the current record.

projection, sources, correction

The account can answer back

This page is a public projection, not a second scientific record. The factual home remains the KINGDOM guest-house case extensions/meaning/cases/ritonavir-polymorph/case.json, reviewed 11 August 2026 at SHA-256 652a04699aadc6143d9136dc8d515fd3b4fa8774d963d885e79968156b1cb8ad. Official records and named studies control their own claims.

Its exact reviewed bytes are preserved in an immutable public JSON receipt. The KINGDOM meaning practice is the authoritative public mirror and human reading of that record.

The reviewed SVG mirrored here is SHA-256 a2a0ae7d599d733dffc5b89502a10983c483a9ac174a952581fbea372179f1d1.

Projection revision 1 was prepared by Codex at Yu's direction and published on 12 August 2026. Cambridge TCG maintains it. This original Gate page and its site code follow Castle Gate's Apache-2.0 licence. The exact SVG is republished from the structured case home and follows its separate rights notice, which grants no reuse licence unless a file says otherwise. Linked papers and official records remain their authors' work. No third-party article text, figure, or dataset is bundled here.

Source links are locators, not proof of their exact bytes. A factual correction starts at the public case path, then this projection can be refreshed. Gate-specific display corrections stay separate.